She said they were currently funding research into drugs that mimic the action of nerve growth factor (NGF), the name given to the gene therapy involving stimulating cell function.

BBC: NEWS | Health | Alzheimer's gene therapy hailed

New Scientist magazine reports that the researchers, led by Mark Tuszynski, of the University of California, San Diego, believe a substance called nerve growth factor (NGF) can prevent the death of cells in the brain known as cholinergenic neurons, and stimulate new connections between the cells.

BBC: 'Brain cell transplant' for Alzheimer's

Earlier this year, Pfizer, which is in the lead with an antibody trageting nerve growth factor one (NGF-1), announced that the Food and Drug Administration had told it to put clinical trials of its drug on hold.

FORBES: Promising Pain Drugs Put On Ice